Literature DB >> 27696170

KRAS Mutation Status Dictates Optimal Surgical Margin Width in Patients Undergoing Resection of Colorectal Liver Metastases.

Georgios A Margonis1,2, Kazunari Sasaki1, Nikolaos Andreatos1, Yuhree Kim1, Katiuscha Merath1, Doris Wagner1, Ana Wilson1, Stefan Buettner1, Neda Amini1, Efstathios Antoniou2, Timothy M Pawlik3.   

Abstract

BACKGROUND: The optimal tumor-free margin width remains controversial and may be inappropriate to investigate without considering differences in the underlying tumor biology.
METHODS: R1 resection was defined as margin clearance less than 1 mm. R0 resection was further divided into 3 groups: 1-4, 5-9, and ≥10 mm. The impact of margin width on overall survival (OS) relative to KRAS status [wild type (wtKRAS) vs. mutated (mutKRAS)] was assessed.
RESULTS: A total of 411 patients met inclusion criteria. Median patient age was 58 years (interquartile range, 49.7-66.7); most patients were male (n = 250; 60.8 %). With a median follow-up of 28.3 months, median and 5-year OS were 69.8 months and 55.1 %. Among patients with wtKRAS tumors, although margin clearance of 1-4 mm or more was associated with improved OS compared to R1 (all P < 0.05), no difference in OS was observed when comparing margin clearance of 1-4 mm to the 5-9 mm and the ≥10 mm groups (all P > 0.05). In contrast, among patients with mutKRAS tumors, all three groups of margin clearance (1-4, 5-9, and ≥10 mm) fared no better in terms of 5-year survival compared to R1 resection (all P > 0.05).
CONCLUSIONS: While a 1-4 mm margin clearance in patients with wtKRAS tumors was associated with improved survival, wider resection width did not confer an additional survival benefit. In contrast, margin status-including a 1 cm margin-did not improve survival among patients with mutKRAS tumors.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27696170     DOI: 10.1245/s10434-016-5609-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  22 in total

Review 1.  Liver metastases.

Authors:  Diamantis I Tsilimigras; Pnina Brodt; Pierre-Alain Clavien; Ruth J Muschel; Michael I D'Angelica; Itaru Endo; Rowan W Parks; Majella Doyle; Eduardo de Santibañes; Timothy M Pawlik
Journal:  Nat Rev Dis Primers       Date:  2021-04-15       Impact factor: 52.329

2.  Response to: "Liver Resection and Role of Extended Cytology and Histology".

Authors:  Luca Vigano; Guido Torzilli
Journal:  J Gastrointest Surg       Date:  2019-03-18       Impact factor: 3.452

Review 3.  Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review.

Authors:  Dimitrios Moris; Sean Ronnekleiv-Kelly; Amir A Rahnemai-Azar; Evangelos Felekouras; Mary Dillhoff; Carl Schmidt; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-03-31       Impact factor: 3.452

Review 4.  Gene mutation and surgical technique: Suggestion or more?

Authors:  Yoshikuni Kawaguchi; Heather A Lillemoe; Jean-Nicolas Vauthey
Journal:  Surg Oncol       Date:  2019-07-18       Impact factor: 3.279

5.  Comparison of lymph node evaluation and yield among patients undergoing open and minimally invasive surgery for gallbladder adenocarcinoma.

Authors:  Ahmad Hamad; Jordan M Cloyd; Mary Dillhoff; Andrei Manilchuk; Timothy M Pawlik; Allan Tsung; Aslam Ejaz
Journal:  Surg Endosc       Date:  2020-05-19       Impact factor: 4.584

6.  PRIMARY TUMOR LYMPHOVASCULAR INVASION NEGATIVELY AFFECTS SURVIVAL AFTER COLORECTAL LIVER METASTASIS RESECTION?

Authors:  Renato Gomes Campanati; João Bernardo Sancio; Lucas Mauro de Andrade Sucena; Marcelo Dias Sanches; Vivian Resende
Journal:  Arq Bras Cir Dig       Date:  2021-06-11

7.  Innovation and Future Perspectives in the Treatment of Colorectal Liver Metastases.

Authors:  Jean-Nicolas Vauthey; Yoshikuni Kawaguchi
Journal:  J Gastrointest Surg       Date:  2019-12-03       Impact factor: 3.452

8.  Peri-tumoral Metallic Implants Reduce the Efficacy of Irreversible Electroporation for the Ablation of Colorectal Liver Metastases.

Authors:  Francois H Cornelis; Helena Cindrič; Bor Kos; Masashi Fujimori; Elena N Petre; Damijan Miklavčič; Stephen B Solomon; Govindarajan Srimathveeravalli
Journal:  Cardiovasc Intervent Radiol       Date:  2019-08-05       Impact factor: 2.740

9.  The Prognostic Value of Varying Definitions of Positive Resection Margin in Patients with Colorectal Cancer Liver Metastases.

Authors:  Jane Wang; Georgios Antonios Margonis; Neda Amini; Nikolaos Andreatos; Chunhui Yuan; Christos Damaskos; Efstathios Antoniou; Nikolaos Garmpis; Stefan Buettner; Carlotta Barbon; Amar Deshwar; Jin He; Richard Burkhart; Timothy M Pawlik; Christopher L Wolfgang; Matthew J Weiss
Journal:  J Gastrointest Surg       Date:  2018-04-09       Impact factor: 3.452

Review 10.  Colorectal Liver Metastases: Does the Future of Precision Medicine Lie in Genetic Testing?

Authors:  Carlotta Barbon; Georgios Antonios Margonis; Nikolaos Andreatos; Neda Rezaee; Kazunari Sasaki; Stefan Buettner; Christos Damaskos; Timothy M Pawlik; Jin He; Christopher L Wolfgang; Matthew J Weiss
Journal:  J Gastrointest Surg       Date:  2018-04-11       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.